Literature DB >> 18776884

Counteracting clotting in sepsis.

Mark L Kahn1.   

Abstract

The complexity of factors that regulate bleeding and coagulation has long confounded researchers. Andrew Wei and Shaun Jackson help clear the air by examining clinical findings pointing to a mechanistic basis for a common bleeding disorder, immune thrombocytopenic purpura. Mark Kahn tackles two research studies that could lead to improved therapies for a coagulation syndrome that hits people with severe sepsis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776884     DOI: 10.1038/nm0908-918

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  3 in total

1.  The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice.

Authors:  Takashi Minami; Kiichiro Yano; Mai Miura; Mika Kobayashi; Jun-ichi Suehiro; Patrick C Reid; Takao Hamakubo; Sandra Ryeom; William C Aird; Tatsuhiko Kodama
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

2.  Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Authors:  Amanda Hurley; Mindy Smith; Tatiana Karpova; Rebecca B Hasley; Natalya Belkina; Stephen Shaw; Nariman Balenga; Kirk M Druey; Erin Nickel; Beverly Packard; Hiromi Imamichi; Zonghui Hu; Dean Follmann; James McNally; Jeanette Higgins; Michael Sneller; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

3.  Assessing thrombin generation at the point of care.

Authors:  T Keith Brock; Nicole L Gentile; Richard F Louie; Nam K Tran; Tyler Kitano; Gerald J Kost
Journal:  Clin Chem       Date:  2009-01-23       Impact factor: 8.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.